KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
NASIBULLIN, T.R.,
AZNABAEVA, Y.G.,
ZULKARNEEV, S.R.,
IZMAǏLOVA, S.M.,
ZAGIDULLIN, S.Z.,
VICTOROVA, T.V. (2021) in nonsmokers. Lower
smoking index were observed in carriers of the GRIK3 (rs534131)
genotype GG and GRIA1 (rs
ASSOCIATIONS OF THE NRF2/KEAP1 PATHWAY AND ANTIOXIDANT DEFENSE GENE POLYMORPHISMS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEKorytina, G.F.,
Akhmadishina, L.Z.,
Aznabaeva, Y.G.,
Kochetova, O.V.,
Zagidullin, N.S.,
Kzhyshkowska, J.G.,
Zagidullin, S.Z.,
Viktorova, T.V. (2019) and
smoking pack-years. The results: In our population, a significant associations of KEAP1 (rs1048290) (P = 0
KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
VIKTOROVA, T.V.,
AZNABAEVA, Y.G.,
ZAGIDULLIN, N.SH.,
ZAGIDULLIN, SH.Z.,
KZHYSHKOWSKA, J.G (2019) analyses were performed to estimate the relationship between SNPs and lung function parameters and
smokingKorytina, G.F.,
Akhmadishina, L.Z.,
Kochetova, O.V.,
Aznabaeva, Y.G.,
Zagidullin, Sh.Z.,
Victorova, T.V. (2016) -by-environment interaction of
smoking status and IL17A (rs1974226) (P interact = 0.016), JAK3 (rs3212780) (P interact = 0
KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
VIKTOROVA, T.V.,
AZNABAEVA, Y.G.,
ZAGIDULLIN, SH.Z. (2019) ); this association was confirmed in the subgroups differentiated by
smoking status. Markers of COPD risk were also
Korytina, G.F.,
Aznabaeva, Y.G.,
Kochetova, O.V.,
Nasibullin, T.R.,
Akhmadishina, L.Z.,
Khusnutdinova, N.N.,
Zagidullin, N. Sh.,
Victorova, T.V. (2023) with age and
smoking pack/years, indicating a high ability of the model to correctly classify individuals